The stiffness of the extracellular matrix is a key factor in tumor progression

Yue Zheng; Xinming Su; Shiwei Duan

doi:10.1002/mco2.729

MedComm ›› 2024, Vol. 5 ›› Issue (9) :e729 DOI: 10.1002/mco2.729

HIGHLIGHT

The stiffness of the extracellular matrix is a key factor in tumor progression

Yue Zheng ¹^,²
, Xinming Su ¹^,³
, Shiwei Duan ¹^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Yue Zheng, Xinming Su, Shiwei Duan. The stiffness of the extracellular matrix is a key factor in tumor progression. MedComm, 2024, 5(9): e729 DOI:10.1002/mco2.729

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bansaccal N, Vieugue P, Sarate R, et al. The extracellular matrix dictates regional competence for tumour initiation. Nature. 2023; 623(7988): 828-835.

[2]	Hernandez LE, Mohsin N, Levin N, Dreyfuss I, Frech F, Nouri K. Basal cell carcinoma: an updated review of pathogenesis and treatment options. Dermatol Ther. 2022; 35(6): e15501.

[3]	Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014; 15(12): 786-801.

[4]	Huang J, Zhang L, Wan D, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021; 6(1): 153.

[5]	Chaudhuri O, Cooper-White J, Janmey PA, Mooney DJ, Shenoy VB. Effects of extracellular matrix viscoelasticity on cellular behaviour. Nature. 2020; 584(7822): 535-546.

RIGHTS & PERMISSIONS

2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.